Incidence and Outcomes of Hip Fractures in Parkinsonism vs Non-Parkinson Population: A Systematic Review of the Literature
Objective: To assess hip fractures incidence in Parkinsonism patients and assess their outcome. Background: Parkinson's disease is associated with gait disturbance, postural instability, and increased…Sleep habits and lifestyle factors in people with Parkinson’s disease compared with healthy controls
Objective: To evaluate the sleep habits and everyday lifestyle of Parkinson's disease (PD) patients compared to the healthy population. Background: Sleep disturbances are common non-motor…Prosodic speech variability is associated with speech-related stigma in Parkinson’s disease
Objective: To investigate whether objective acoustic speech parameters are associated with perceived speech-related stigma in Parkinson’s disease (PD). Background: Speech impairment is common in PD…Clinical Profile and Progression of Parkinson’s Disease in Nigerians with the GBA1 African Ancestry-specific Risk Variant
Objective: This study compares clinical features and disease progression across rs3115534 genotypes (G/G, G/T, T/T) in Nigerians with Parkinson's disease (PD). Background: Variants in GBA1 are major…Age of Onset as a Predictor of NonMotor Symptom Severity in Parkinson’s Disease
Objective: To examine the influence of age of onset on the non-motor symptom (NMS) burden among individuals with Parkinson’s disease (PD) in Singapore. Background: Non-motor…Regional Basal Ganglia Hypoperfusion in Early Parkinson’s Disease: Evidence from CT Perfusion Imaging
Objective: To characterize region-specific cerebral perfusion alterations within the basal ganglia in patients with early-stage Parkinson's disease using quantitative CT perfusion imaging. Background: Emerging evidence…Beyond Motor Outcomes: Health Literacy, Medication Adherence, and Quality of Life in Parkinson’s Disease Patients Undergoing the Levodopa Challenge Test
Objective: To characterize health literacy (HL), medication adherence, satisfaction with medication information, and quality of life (QoL) in Parkinson’s disease (PD) patients undergoing the levodopa…Inpatient Titration Protocol and Practical Implementation of Continuous Subcutaneous Foslevodopa/Foscarbidopa: Lessons from 28 Consecutive Cases
Objective: To describe inpatient titration methodology, dosing parameters, support services utilization, and early challenges in consecutive advanced PD patients. Background: Successful implementation of continuous subcutaneous…Genetic determinants of cognitive performance in Parkinson’s disease: impact of distal regulatory variation at the SNCA locus in the gp2 cohort
Objective: This study evaluates the association between a distal regulatory haplotype at the SNCA locus and cognitive performance, measured by the Montreal Cognitive Assessment (MoCA),…From Clinic to Home: Transitioning a Reduced Wearable Sensor Monitoring Array in Parkinson’s Disease
Objective: To assess the validity of a remote wearable sensor protocol performed at home with a simplified sensor configuration in people with Parkinson’s Disease (PwP).…
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 553
- Next Page »
